This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
Aleksandra Zuraw from Digital Pathology Place discusses digital pathology from the basic concepts to the newest developments, including image analysis and artificial intelligence. She reviews scientific literature and together with her guests discusses the current industry and research digital pathology trends.
…
continue reading
Round table discussion format focusing on recent events in the healthcare space, published monthly by thought leaders at Pharma Intelligence. https://pharmaintelligence.informa.com/
…
continue reading
Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intell ...
…
continue reading
The Future of Pharma with ISPE Boston. Find out where the pharmaceutical industry is headed and what it means for you. Join host Samir Gondalia as he chats with the thought leaders of the pharma world about the new technologies, innovative applications and emerging markets and how it’s going to influence the future of Pharma.
…
continue reading
Discover the transformative power of GenAI, Data Analytics, Social Intelligence, and Physician Influencer Marketing that is shaping the future of pharma marketing. Join us, as we pave the pathway to a novel pharma marketing landscape, bringing to you conversations that meet at the intersection of technology and marketing. Hosted by Saumya Prakash, Co-Founder Multiplier AI Solutions, this podcast is spearheading the dialogues on disruptions in pharma marketing. Know more about us at: https:// ...
…
continue reading
Intelligent Automation – a powerful confluence of Process Intelligence, Intelligent Document Processing, RPA, Low Code/No Code application development, and Intelligent Virtual Agents, built on a stack of Advanced Intelligence capabilities, powered by Generative AI and supported by Next-gen Infrastructure. It empowers enterprises to drive integrated human experience outcomes, powered by agile configurable workflows.
…
continue reading
A weekly podcast discussion about asymmetric learning - how organisations gain competitive advantage through their approach to learning, in all its forms. We will talk with thought leaders and experts to understand processes and systems of learning that lead to outperformance.
…
continue reading
Welcome to 'Controversial as Fuck' with Hollie Wild, where thought leaders and industry changers converge to amplify voices often silenced and tackle the taboo. Each episode delves into the tough discussions surrounding big pharma, mainstream media, social justice movements, and beyond, grilling the sacred cows of our time. This isn't just a podcast—it's a revolution for those who dare to think differently, engage in conversations that drive real change, and inspire resilience across mental, ...
…
continue reading
A podcast by venture capital firm Lux Capital on the opportunities and risks of science, technology, finance and the human condition. Hosted by Danny Crichton from our New York City studios.
…
continue reading
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
…
continue reading
AI50 navigates the forefront of technology, delving into the nuances of artificial intelligence, especially focusing on Microsoft's Fabric and Azure AI platforms. Each episode illuminates the latest in scientific innovation, with a special lens on how these advancements interface with the aging population. We unravel the complexities of AI and technology's role in society, providing deep insights and thoughtful analysis. Join us as we explore the ever-changing world of technology, unveiling ...
…
continue reading
Science Will Win is a podcast that takes listeners under the microscope of some of the most promising medical innovations, exploring therapies that have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates, and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating scie ...
…
continue reading
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
…
continue reading
Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more. Hosted on Acast. See acast.com/privacy for more information.
…
continue reading
Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com
…
continue reading
Providing insights to HR leaders around their greatest challenge - their People
…
continue reading
![Artwork](/static/images/128pixel.png)
1
100: AI in Pathology: DigiPath Digest #9 (From Retinal Assessment to Tumor Prognostics)
43:12
43:12
Play later
Play later
Lists
Like
Liked
43:12
Send us a Text Message. In this episode, we celebrate the 100th edition of the Digital Pathology Podcast! Thank you so much for being part of this journey! You are my Digital Pathology Trailblazers and I prepared a Digital Pathology Trailblazer manifesto for us! This is the 9th edition of DigiPath Digest, and we are attracting more and more people …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Orthogonal Bet: Understanding Embodied Intelligence
44:19
44:19
Play later
Play later
Lists
Like
Liked
44:19
Welcome to The Orthogonal Bet, an ongoing mini-series that explores the unconventional ideas and delightful patterns that shape our world. Hosted by Samuel Arbesman. In this episode, Sam speaks with Michael Levin, a biologist and the Vannevar Bush Professor at Tufts University. Michael’s work encompasses how information is processed in biol…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Stay Informed on the Latest Industry News
2:49
2:49
Play later
Play later
Lists
Like
Liked
2:49
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Leqembi, a new biotech drug, has been approved in the UK, but reimbursement may not follow due to concerns about the cost to the NHS. The FDA defended its med device chief's tenure after ethics concerns were raised. Employe…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
August 2024 Datamonitor Healthcare Podcast: The Colorful Landscape of Therapeutic Psychedelics
15:22
15:22
Play later
Play later
Lists
Like
Liked
15:22
Following the recent FDA rejection of MDMA therapy for PTSD, Emma and Flora discuss the future role of psychedelics in the treatment of mental health disorders. Content warning: This episode does contain mentions of sexual assault and abuse.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcas…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EP 148: Advancing veteran health through the Million Veteran Program with Dr. Mike Gaziano, professor of medicine at Harvard Medical School
35:13
35:13
Play later
Play later
Lists
Like
Liked
35:13
0:00 Intro 2:00 Mike’s career prior to the Million Veteran Program (MVP), how Mike got to work on MVP, and important milestones in the project's evolution 8:30 Future goals for the Million Veteran Program in expanding and diversifying the research cohort 11:00 The roles of various omics in advancing the project's development 14:30 The most meaningf…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: August 21, 2024 - Leadership Changes, FDA Setbacks, and Industry Updates
1:58
1:58
Play later
Play later
Lists
Like
Liked
1:58
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Biopharma news on August 21, 2024 saw changes in Biomarin's C-suite, with Greg Friberg and James Sabry taking over R&D and business development. BridgeBio launched GondolaBio for rare disease drug programs, while Regener…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ep. 20 | 🍿Comment Chaos: Stirring the Pot in the Digital Age
24:59
24:59
Play later
Play later
Lists
Like
Liked
24:59
In this unapologetic episode of "Comment Chaos," I take on the madness of TikTok censorship, the audacity of social media trolls, and the polarizing debates that light up the internet. From the absurdity of follower counts to the deep-rooted issues of self-authority, this episode is a no-holds-barred exploration of the digital battleground. Tune in…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Radical Uncertainty, Rapid Learning and the Success Equation for Catching Up
47:29
47:29
Play later
Play later
Lists
Like
Liked
47:29
Global inequality has grown over the past two decades, concentrating an enormous amount of wealth and power on an elite number of individuals, cities, regions and nations all while stranding the vast masses to ignominy and penury. Yet, history is replete with examples of people and places that have caught up — and in some cases even surpassed — onc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Stay Informed on the Latest Industry Updates
2:26
2:26
Play later
Play later
Lists
Like
Liked
2:26
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.J&J has acquired heart failure implant maker V-Wave for up to $1.7 billion, while Medtronic reiterates its unchanged diabetes strategy despite a partnership with Abbott. Histosonics secured $102 million for a noninvasive …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Evolving landscape of personalized Pharma Marketing with Dr. Kavita Lamror
27:58
27:58
Play later
Play later
Lists
Like
Liked
27:58
Explore the dynamic shift from traditional to digital marketing strategies in the pharmaceutical sector that is being triggered and drive by GenAI. Join us for a fascinating conversation with Dr. Kavita Lamror, a leading expert in real-world evidence and digital transformation at Maxis Clinical Sciences. In this episode, Dr. Kavita delves into how …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Your Essential Guide to Industry Updates
2:30
2:30
Play later
Play later
Lists
Like
Liked
2:30
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.On August 19, 2024, the FDA approved the first at-home syphilis test by NowDiagnostics, providing quick results with just a drop of blood. Dupont acquired Donatelle Plastics for $313 million, while Boston Scientific resub…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ep. 19 | Trauma, Psychedelics, the Patriarchy, Controlled Opposition and Jesus: Uncut with Holly Loxton
1:30:20
1:30:20
Play later
Play later
Lists
Like
Liked
1:30:20
Dive into an unfiltered conversation with powerhouse Holly Loxton as we explore trauma, healing, and the transformative power of psychedelics. We'll challenge the concept of the patriarchy and dissect its impact on our lives. Prepare for thought-provoking discussions on politics, religion, and the New Age movement, all with a focus on questioning e…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bioprinting – An Innovative Tool That Is Revolutionizing Drug Discovery
41:14
41:14
Play later
Play later
Lists
Like
Liked
41:14
Keith Murphy, co-founder of Organovo, discusses the growing potential of bioprinting and how the company is using its technologies to study and develop treatments for inflammatory bowel disease (IBD).By Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Cutting through the noise in the world of healthcare.
2:33
2:33
Play later
Play later
Lists
Like
Liked
2:33
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Medicare has revealed the results of drug price negotiations, showing $6 billion in savings for taxpayers from talks involving drugs like Eliquis and Xarelto. Lilly has opened an R&D hub in Boston, while Ovid and Lexicon ar…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 19 August 2024
15:10
15:10
Play later
Play later
Lists
Like
Liked
15:10
Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 August 2024. In this episode: Merck & Co. steps into CD19 bispecific space; gene therapy patients rise, but slowly; Madrigal’s Rezdiffra plans; Korean biopharma financing recovering?; and approvals to watch out for in Q3.https://scrip.citeline.com/SC1507…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Fix: What We Learned From The First Batch Of Medicare Negotiated Drug Prices
35:44
35:44
Play later
Play later
Lists
Like
Liked
35:44
Pink Sheet reporter and editors discuss the take-aways from the landmark first Medicare negotiated drug prices and what additional information remains outstanding.More On These Topics From The Pink SheetMedicare Negotiation Announcement: Discounts From List Price Up To 79%, But Net Savings Unclear: https://pink.citeline.com/PS155128/Medicare-Negoti…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Orthogonal Bet: The Quest to Build the Fruitful Web
23:27
23:27
Play later
Play later
Lists
Like
Liked
23:27
Welcome to The Orthogonal Bet, an ongoing mini-series that explores the unconventional ideas and delightful patterns that shape our world. Hosted by Samuel Arbesman. In this episode, Sam speaks with Laurel Schwulst. Laurel operates within many roles: designer, artist, educator, and technologist. She explores—among other things—the intersectio…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Senior Living Redefined: Cultivating Community with Steve Lindsey
45:36
45:36
Play later
Play later
Lists
Like
Liked
45:36
Dive into an inspiring chat with Steve Lindsey, CEO of Garden Spot Village, where we explore the transformative power of purpose in senior living. Discover how purpose, engagement, and community culture redefine experiences for both staff and residents. Learn about cross-generational connections and the evolution of a thriving organization. Get rea…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: The Latest in Gene Therapy, Drug Pricing, and Cancer Research
4:24
4:24
Play later
Play later
Lists
Like
Liked
4:24
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Evotec is exiting the gene therapy field and cutting jobs due to a slowdown in research spending. Merck has made a $700 million bet on an antibody drug for immune diseases, while Lilly has opened a new R&D hub in Boston. Ov…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EP 147: From research to delivering precision medicine in the clinic with Scott Weiss, Professor of Medicine at Harvard University
37:19
37:19
Play later
Play later
Lists
Like
Liked
37:19
0:00 Intro to The Genetics Podcast 01:00 Welcome to Scott 01:55 Scott’s career highlights to date, ranging from epidemiology to the genetics of asthma and chronic obstructive pulmonary disease (COPD) 04:56 How and why Scott decided to transition into genetics 06:30 The advances in our understanding of the genetics of asthma and COPD over the past 2…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Industrial literacy and the fate of American progress
39:06
39:06
Play later
Play later
Lists
Like
Liked
39:06
It’s good and bad times in America. Inflation is down and wages are up in real terms, but there’s a rising challenge: how can we provide the housing, transportation, schooling, health care and amenities that Americans expect when prices for these social services have skyrocketed over the past three decades? Even when new technologies are capable of…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Biotech Buzz: The Latest News and Trends in Pharma and Biotech
2:41
2:41
Play later
Play later
Lists
Like
Liked
2:41
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The FDA recently approved Ascendis' drug for a rare endocrine condition, while rejecting MDMA as a therapy aid for PTSD. Pfizer also presented data supporting a case for an RSV shot for immunocompromised adults. Zepbound sh…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
【3分で解説 世界のファーマ】第20回 欧州心臓病学会 注目の新薬候補は (Japanese-language podcast)
3:03
3:03
Play later
Play later
Lists
Like
Liked
3:03
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちらWhat To Look Out For At ESC 2024https://scrip.citeline.com/SC150740/What-To-Look-Out-For-At-ESC-2024By Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ep. 18 | 🍿Comment Chaos: TikTok Censorship, Online Outrage, and Cultural Clashes
26:01
26:01
Play later
Play later
Lists
Like
Liked
26:01
In this fast-paced episode of Comment Chaos, I tackle TikTok censorship, dissect the latest social media uproars, and dive into the cultural clashes stirring up heated debates. From the struggles of free speech online to the chaos that ignites across platforms, this episode unpacks the challenges that come with sharing bold opinions in a highly cha…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Sustainable By Design: Thermo Fisher's Meron Mathias On ESG Compliance And The Competitive Edge
29:47
29:47
Play later
Play later
Lists
Like
Liked
29:47
Compliance with environmental sustainability goals is no longer optional for medtech companies serving global healthcare markets. Thermo Fisher has made it a mission to be a leader in thought and actions in meeting Scope 1, 2 and 3 needs. Corporate VP and head of sustainability Meron Mathias explains the company's sustainability aims and methods, f…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Innovations and Insights: Your Daily Dose of Pharma and Biotech News
4:29
4:29
Play later
Play later
Lists
Like
Liked
4:29
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Steward, a bankrupt healthcare organization, is set to sell its physician group to a private equity firm for $245 million. Kaiser's operating margin has risen to 3.1% in the second quarter, indicating a strong performance …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
From Lab Coats to Boardrooms, Decoding Pharma's Global Marketing Evolution
33:26
33:26
Play later
Play later
Lists
Like
Liked
33:26
Can you imagine how exclusivity showcased the critical importance of adaptable strategies in the pharmaceutical industry? In this episode, embark on an illuminating journey through the evolution of pharmaceutical marketing as your host Soumya Prakash engages in a thought-provoking dialogue with industry luminary Salil Kallianpur. In this podcast Mr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Your Quick Update on Industry News and Trends
4:02
4:02
Play later
Play later
Lists
Like
Liked
4:02
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA approved Ascendis' drug for a rare endocrine condition, while rejecting MDMA as a therapy aid for PTSD. Pfizer presented new data on their RSV shot for immunocompromised adults. Halda, a startup, raised $126 milli…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 13 August 2024
15:29
15:29
Play later
Play later
Lists
Like
Liked
15:29
Audio roundup of selected biopharma industry content from Scrip over the business week ended 9 August 2024. In this episode: Amgen positions for obesity and diabetes; BMS returns TIGIT asset in pipeline reshuffle; is Kerendia the next jewel in Bayer’s crown?; Japan pharma firms cut jobs; and Sun Pharma seeks GLP-1 partner.https://scrip.citeline.com…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ep. 17 | Beyond Religion: Past Lives, Karma, Universal Laws & Spiritual Intelligence with James Pask
1:23:27
1:23:27
Play later
Play later
Lists
Like
Liked
1:23:27
In this profound episode of 'Controversial as Fuck,' I sit down with James Pask, a metaphysical teacher and healing facilitator, to delve deep into spiritual intelligence and the journey of self-discovery. We discuss the transformative power of going within, exploring past lives, karma, universal laws, and the nature of spiritual intelligence. Jame…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Why Purpose Is Key To Driving CHC Growth, With Haleon’s Bas Vorsteveld
40:19
40:19
Play later
Play later
Lists
Like
Liked
40:19
Since becoming a standalone consumer health company, Haleon has been driving awareness of public health issues such as chronic pain and children’s oral health. In this episode of Over the Counter, HBW Insight catches up with Haleon vice president and general manager Great Britain and Ireland Bas Vorsteveld, to find out more about why having a purpo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: The Latest in Drug Partnerships, Market Trends, and Legal Battles
3:47
3:47
Play later
Play later
Lists
Like
Liked
3:47
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Abbott and Medtronic have announced a partnership to develop diabetes technology, with Abbott creating a glucose sensor that will only connect with Medtronic's insulin delivery technology. Nevro is considering a sale in res…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Fix: Clinical Trial Diversity, Off-Label Standard Of Care Issues, In-Person US FDA Adcomms
33:10
33:10
Play later
Play later
Lists
Like
Liked
33:10
Pink Sheet reporter and editors discuss former Surgeon General Jerome Adams’ views on how the FDA can better ensure clinical trial diversity (:27), questions about approving a new drug that would be used with a standard of care regimen that is off-label (15:00), and the agency beginning to schedule fully in-person advisory committee meetings (24:03…
…
continue reading
In this audio, Dr. Anthony Fritz discusses Type 2 diabetes and the benefits of SGLT2 inhibitors. Learn how this treatment option can improve diabetes care.By Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
99: DigiPath Digest #7 (Exploring AI-driven advances in digital pathology from T-cell signatures to synthetic images)
44:25
44:25
Play later
Play later
Lists
Like
Liked
44:25
Send us a Text Message. In this episode of DigiPath Digest, broadcasting from Poland, we delve into advances in digital pathology, including AI applications in bone marrow evaluation, classification of hematology cells, and the use of synthetic images for data augmentation. Additionally, we review a survey on pathologists' perceptions of ChatGPT an…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Orthogonal Bet: : The Art of Cultivating Curiosity
35:55
35:55
Play later
Play later
Lists
Like
Liked
35:55
Welcome to The Orthogonal Bet, an ongoing mini-series that explores the unconventional ideas and delightful patterns that shape our world. Hosted by Samuel Arbesman. In this episode, Sam speaks with Eliot Peper. Eliot is a science fiction novelist and all-around delightful thinker. Eliot’s books are thrilling tales of the near future, exploring…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Real-World Data in Clinical Trials, CMS Pathways, and Industry Updates
1:53
1:53
Play later
Play later
Lists
Like
Liked
1:53
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Learn how real-world data (RWD) can be utilized in clinical trials to create more diverse control arms and expedite the process of bringing therapies to market. The FDA's considerations for sponsors using RWD in external …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Why engineers are using chaos to make computers more resilient
34:23
34:23
Play later
Play later
Lists
Like
Liked
34:23
The CrowdStrike meltdown on July 19th shut down the world with one faulty patch — proving once again the interconnected fragility of global IT systems. On Tuesday this week, the company released its Root Cause Analysis as both an explanation and a mea culpa, but the wider question remains: with so much of our lives dependent on silicon and electron…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Your Essential Weekly Roundup
4:09
4:09
Play later
Play later
Lists
Like
Liked
4:09
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.This week in biopharma news, Novo's stock experienced a sell-off due to lower-than-expected obesity drug sales, Madrigal's new drug launch exceeded expectations, and Biomarin is focusing on narrowing its sales focus for its…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EP 146: The biology of aging with Austin Argentieri, Research Fellow at Harvard Medical School, Affiliate Member of the Broad Institute, and Research Fellow at Massachusetts General Hospital
43:05
43:05
Play later
Play later
Lists
Like
Liked
43:05
0:00 Intro to The Genetics Podcast 01:00 Welcome to Austin 01:42 What is aging and how should we think about it? 03:50 Discussion of Austin’s recent breakthrough paper on aging, including the questions he set out to answer, and the outcomes of the research 06:32 How Austin’s work focuses on using large-scale population proteomics data to create acc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ep. 16 | 🍿Comment Chaos: Followers, Feedback, and Fierce Opinions
28:15
28:15
Play later
Play later
Lists
Like
Liked
28:15
In this episode of 'Comment Chaos,' I dive into the most chaotic, controversial, and insightful comments from my social media platforms. From Instagram to TikTok, I address a viral reel on the feminist movement and a bold stance on gender identity and kids. Join me as I discuss the significance of follower count, the importance of discernment in so…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Biotech Buzz: The Latest in Pharma and Biotech News
3:12
3:12
Play later
Play later
Lists
Like
Liked
3:12
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Small biopharma and contract research organizations are increasingly adopting eClinical technology to keep up with regulatory and market demands for research innovation. They are paying attention to how these tools can help…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
비만치료제, 2024년 상반기 대형주를 지배하다 (Korean-language podcast)
3:24
3:24
Play later
Play later
Lists
Like
Liked
3:24
올해 상반기 일라이 릴리와 노보 노디스크의 주가가 가장 높은 상승세를 보인 반면, BMS와 길리어드의 주가는 가장 큰 폭으로 하락했습니다. Scrip의 글로벌 제약주 동향 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150593/Obesity-Rules-Large-Cap-Stocks-In-First-Half-Of-2024By Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: The Latest in Layoffs, Partnerships, and Therapeutic Advances
2:48
2:48
Play later
Play later
Lists
Like
Liked
2:48
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Steward Health plans to lay off over 1,200 workers in Massachusetts and close two hospitals. Walgreens has reduced its stake in Cencora for $1.1 billion. The cost of healthcare data breaches is nearly $10 million in 2024, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ep. 15 | The CIA, the Cold War, and Feminism: Who’s Really in Control?
1:05:53
1:05:53
Play later
Play later
Lists
Like
Liked
1:05:53
Join me on a gripping journey as we delve into the hidden agendas of the CIA, the intricacies of the Cold War, and the feminist movement like never before. In this episode, we explore the potential covert operations and influence of the CIA on social movements, specifically feminism, and ask some thought-provoking questions: How deep do the connect…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: The Latest Updates in the Industry
2:03
2:03
Play later
Play later
Lists
Like
Liked
2:03
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Pfizer is terminating its Duchenne gene therapy program, resulting in the layoff of 150 staff members. Boehringer has acquired startup Nerio for up to $1.3 billion to expand its cancer drug pipeline. Emerging biotech IPOs…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 5 August 2024
15:19
15:19
Play later
Play later
Lists
Like
Liked
15:19
Audio roundup of selected biopharma industry content from Scrip over the business week ended 2 August 2024. In this episode: Pfizer bullish on its oral GLP-1; BMS’s rising confidence about Medicare pricing of Eliquis; more long term data for Leqembi; NewAmsterdam’s CETP inhibitor shows promise; and a look at Mankind’s Bharat Serums buy.https://scri…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
98: DigiPath Digest #6 (Foundation models high level overview)
49:33
49:33
Play later
Play later
Lists
Like
Liked
49:33
Send us a Text Message. Exploring Foundation Models in Digital Pathology: Insights and Tools In today's DigiPath Digest we talk about the foundation models in pathology. reviewing abstracts from two notable papers in Nature. We discuss the high-level overview of these models, including Hamid Tizhoosh's insights on the vast data requirements for dev…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Fix: August User Fee Goals, Oncology Trial Design Issues, EMA Review Changes
38:50
38:50
Play later
Play later
Lists
Like
Liked
38:50
Pink Sheet reporter and editors discuss the US FDA drug approval decisions that could arrive in August (:34), a trial design issue that could ensnare BMS’ Opdivo along with AstraZeneca’s Imfinzi (10:11), and the EMA potentially asking all sponsors to provide raw clinical data as part of application reviews (33:14).More On These Topics From The Pink…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Orthogonal Bet: Building a Fractal Combinatorial Trope Machine
45:33
45:33
Play later
Play later
Lists
Like
Liked
45:33
Welcome to the ongoing mini-series The Orthogonal Bet. Hosted by Samuel Arbesman, a Complexity Scientist, Author, and Scientist in Residence at Lux Capital. In this episode, he speaks with Hilary Mason, co-founder and CEO of Hidden Door, a startup creating a platform for interactive storytelling experiences within works of fiction. Hilary has als…
…
continue reading